163 related articles for article (PubMed ID: 8374044)
1. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.
Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF
Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044
[TBL] [Abstract][Full Text] [Related]
2. Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry.
Roberts ES; Hopkins NE; Zaluzec EJ; Gage DA; Alworth WL; Hollenberg PF
Biochemistry; 1994 Mar; 33(12):3766-71. PubMed ID: 8142377
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene.
Roberts ES; Hopkins NE; Zaluzec EJ; Gage DA; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1995 Nov; 323(2):295-302. PubMed ID: 7487091
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of cytochrome P450 2B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables.
Goosen TC; Kent UM; Brand L; Hollenberg PF
Chem Res Toxicol; 2000 Dec; 13(12):1349-59. PubMed ID: 11123978
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
6. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.
He K; Falick AM; Chen B; Nilsson F; Correia MA
Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.
Roberts ES; Hopkins NE; Foroozesh M; Alworth WL; Halpert JR; Hollenberg PF
Drug Metab Dispos; 1997 Nov; 25(11):1242-8. PubMed ID: 9351899
[TBL] [Abstract][Full Text] [Related]
8. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites.
Kent UM; Mills DE; Rajnarayanan RV; Alworth WL; Hollenberg PF
J Pharmacol Exp Ther; 2002 Feb; 300(2):549-58. PubMed ID: 11805216
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies of 9-ethynylphenanthrene-inactivated cytochrome P450 2B1.
Roberts ES; Ballou DP; Hopkins NE; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1995 Nov; 323(2):303-12. PubMed ID: 7487092
[TBL] [Abstract][Full Text] [Related]
10. A role for threonine 302 in the mechanism-based inactivation of P450 2B4 by 2-ethynylnaphthalene.
Roberts ES; Pernecky SJ; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1996 Jul; 331(2):170-6. PubMed ID: 8660695
[TBL] [Abstract][Full Text] [Related]
11. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1.
Roberts ES; Lin Hl; Crowley JR; Vuletich JL; Osawa Y; Hollenberg PF
Chem Res Toxicol; 1998 Sep; 11(9):1067-74. PubMed ID: 9760281
[TBL] [Abstract][Full Text] [Related]
12. The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis.
Lin HL; Kent UM; Zhang H; Waskell L; Hollenberg PF
J Pharmacol Exp Ther; 2004 Dec; 311(3):855-63. PubMed ID: 15302894
[TBL] [Abstract][Full Text] [Related]
13. Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl.
Yun CH; Hammons GJ; Jones G; Martin MV; Hopkins NE; Alworth WL; Guengerich FP
Biochemistry; 1992 Nov; 31(43):10556-63. PubMed ID: 1420171
[TBL] [Abstract][Full Text] [Related]
14. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate.
Kent UM; Yanev S; Hollenberg PF
Chem Res Toxicol; 1999 Apr; 12(4):317-22. PubMed ID: 10207119
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
He K; Woolf TF; Hollenberg PF
J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590
[TBL] [Abstract][Full Text] [Related]
17. Suicide inhibitors of cytochrome P450 1A1 and P450 2B1.
Hopkins NE; Foroozesh MK; Alworth WL
Biochem Pharmacol; 1992 Aug; 44(4):787-96. PubMed ID: 1510726
[TBL] [Abstract][Full Text] [Related]
18. Cumene hydroperoxide-mediated inactivation of cytochrome P450 2B1. Identification of an active site heme-modified peptide.
Yao K; Falick AM; Patel N; Correia MA
J Biol Chem; 1993 Jan; 268(1):59-65. PubMed ID: 8416964
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole.
Kent UM; Bend JR; Chamberlin BA; Gage DA; Hollenberg PF
Chem Res Toxicol; 1997 May; 10(5):600-8. PubMed ID: 9168259
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2002 Apr; 301(1):160-7. PubMed ID: 11907170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
